Jump to navigation Jump to search
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Molar mass387.48 g/mol
3D model (JSmol)

WikiDoc Resources for Urapidil


Most recent articles on Urapidil

Most cited articles on Urapidil

Review articles on Urapidil

Articles on Urapidil in N Eng J Med, Lancet, BMJ


Powerpoint slides on Urapidil

Images of Urapidil

Photos of Urapidil

Podcasts & MP3s on Urapidil

Videos on Urapidil

Evidence Based Medicine

Cochrane Collaboration on Urapidil

Bandolier on Urapidil

TRIP on Urapidil

Clinical Trials

Ongoing Trials on Urapidil at Clinical Trials.gov

Trial results on Urapidil

Clinical Trials on Urapidil at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Urapidil

NICE Guidance on Urapidil


FDA on Urapidil

CDC on Urapidil


Books on Urapidil


Urapidil in the news

Be alerted to news on Urapidil

News trends on Urapidil


Blogs on Urapidil


Definitions of Urapidil

Patient Resources / Community

Patient resources on Urapidil

Discussion groups on Urapidil

Patient Handouts on Urapidil

Directions to Hospitals Treating Urapidil

Risk calculators and risk factors for Urapidil

Healthcare Provider Resources

Symptoms of Urapidil

Causes & Risk Factors for Urapidil

Diagnostic studies for Urapidil

Treatment of Urapidil

Continuing Medical Education (CME)

CME Programs on Urapidil


Urapidil en Espanol

Urapidil en Francais


Urapidil in the Marketplace

Patents on Urapidil

Experimental / Informatics

List of terms related to Urapidil

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Urapidil is a sympatholytic antihypertensive drug. It acts as an α1-adrenoceptor antagonist and as an 5-HT1A receptor agonist[1] Although an initial report suggested that urapidil was also an α2-adrenoceptor agonist,[2] this was not substantiated in later studies that demonstrated it was devoid of agonist actions in the dog saphenous vein and the guinea-pig ileum.[3] Unlike some other α1-adrenoceptor antagonists, urapidil does not elicit reflex tachycardia, and this may be related to its weak β1-adrenoceptor antagonist activity,[4][5] as well as its effect on cardiac vagal drive.[6] Urapidil is currently not approved by the U.S. Food and Drug Administration, but it is available in Europe.

See Also


  1. Ramage AG (April 1991). "The mechanism of the sympathoinhibitory action of urapidil: role of 5-HT1A receptors". Br. J. Pharmacol. 102 (4): 998–1002. PMC 1917978. PMID 1855130.
  2. Eltze M (1979). "Investigations on the mode of action of a new antihypertensive drug, urapidil, in the isolated vas deferens". Eur. J. Pharmacol. 59 (1–2): 1–9. doi:10.1016/0014-2999(79)90018-9. PMID 228944.
  3. Verberne AJM, Rand MJ (1984). "Pharmacological activities of the antihypertensive drug urapidil in the rat". Clin. Exp. Pharmacol. Physiol. 11 (4): 407–412. doi:10.1111/j.1440-1681.1984.tb00289.x. PMID 6097380.
  4. Schoetensack W, Bruckschen EG, Zech K (1983). Urapidil. New Drugs Annual: Cardiovascular Drugs. p. 19.
  5. Verberne AJM, Rand MJ (1985). "Effect of urapidil on β-adrenoceptors of rat atria". Eur. J. Pharmacol. 108 (2): 193–196. doi:10.1016/0014-2999(85)90725-3. PMID 2984023.
  6. Ramage AG (1990). "Influence of 5-HT1A receptor agonists on sympathetic and parasympathetic nerve activity". J. Cardiovasc. Pharmacol. 15: S75–S85. PMID 1702490.